Double-blind trial of denosumab vs. zoledronic acid for bone disease in NDMM
Evangelos Terpos • 5 Oct 2018
Imaging modalities and treatment breakthroughs in myeloma bone disease
Meletios Dimopoulos • 12 Sep 2018
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.